Hematopoietic stem cell transplantation (HSCT) use in CLL decreased by 42% from 2009 to 2018 due to new treatment options. Non-relapse mortality (NRM) improved significantly, attributed to enhanced ...
Pulmonary function remained stable -- and in some ways improved -- among patients with sickle cell disease (SCD) who underwent non-myeloablative hematopoietic cell transplant (HCT), a prospective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results